pharmaphorum

JUNE 20, 2022

The rumour was first published in the Wall Street Journal, which suggests that a takeover is just one option on the table, along with a marketing deal that would bind the two companies together without the risk of antitrust issues holding up or blocking a merger. It says Merck has hesitation about whether a deal could make it through FTC.

Sales 102

Sales Marketing Drugs Licensing 102

BioTech 365

JANUARY 19, 2021

EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Mergers & Acquisitions 20.01.2021 / 07:00 Relief and AdVita Sign Binding Term Sheet for Relief to Acquire All Shares of AdVita to Expand Scope of Development of Inhaled Formulation of Aviptadil … Continue reading →

Development 40

Development 40

BioTech 365

JANUARY 6, 2021

DGAP-News: B.R.A.I.N. Biotechnology Research And Information Network AG / Key word(s): Mergers & Acquisitions/Takeover 07.01.2021 / 08:00 The issuer is solely responsible for the content of this announcement.

Production 40

Production Research 40

ECRG Media's Clinical Research Podcast

AUGUST 22, 2018

In 2017 the job requisitions were very slow and now they are heating because there are no mergers and acquisitions like i predicted back in 2017. Don't forget to Subscribe for new content! Don't forget to Subscribe for new content! The clinical research job market is heating up in 2018.

Clinical Research 52

Clinical Research Research Marketing 52

ECRG Media's Clinical Research Podcast

AUGUST 22, 2018

In 2017 the job requisitions were very slow and now they are heating because there are no mergers and acquisitions like i predicted back in 2017. Don't forget to Subscribe for new content! Watch: » Industry News: [link] » All Videos: [link] » Interview Recaps: [link] » Glassdoor Reviews: [link].

Clinical Research 52

Clinical Research Research Marketing 52

XTalks

JUNE 9, 2021

In the food and beverage industry, mergers and acquisitions are big news. In response, Nestlé told Food Business News it is “working on a company-wide project to update its pioneering nutrition and health strategy.” So, why are these two food giants changing directions? Mondelez Considering Popping Gum Business.

Sales 71

Sales Production Branding 71

pharmaphorum

SEPTEMBER 18, 2020

We take a look at the company’s story, from its creation as a merger of two equals, to its recent major restructuring and its drives in cutting-edge oncology and COVID-19. The fusion between Swedish pharmaceutical company, Astra AB, and UK-based Zeneca Group plc, was one of the largest-ever European mergers at the time.

Pharma Companies 113

Pharma Companies Sales Vaccination Vaccine 113

pharmaphorum

DECEMBER 14, 2021

If it goes through, the merger will allow CSL to diversify its business which is focused mainly on plasma-derived medicines sold by its CSL Behring unit and vaccines under the Seqirus arm, adding drugs for iron deficiency and cardio-renal disease that brought in sales of $1.85 billion last year. stake in the company.

Vaccination 52

Vaccination Vaccine Sales Medicine 52

The Pharma Data

AUGUST 19, 2020

This acquisition provides an opportunity for the Janssen Pharmaceutical Companies of Johnson & Johnson to broaden its leadership in immune-mediated diseases and drive further growth through expansion into autoantibody-driven disease. Nipocalimab recently received a rare pediatric disease designation from the U.S. An estimated 2.5

Production 52

Production Dermatology Development Containment 52

pharmaphorum

APRIL 23, 2021

billion acquisition of Tesaro, for certain patients with endometrial cancer. . After a string of disappointments including the failure of bintrafusp alfa , a drug developed with Germany’s Merck KGaA in lung cancer, any approval is welcome news.

FDA Approval 52

FDA Approval Marketing Drugs Licensing 52

pharmaphorum

DECEMBER 2, 2020

Here we take a look at the colourful history of one of the biggest drugmakers in the world. Pfizer was founded in 1849 by two recent German immigrants to the USA, Charles Pfizer and Charles Erhart. It was a success, and set the pattern for the company’s future development. Pfizer’s Tokyo building.

Sales 127

Sales Production Drugs Marketing 127

pharmaphorum

MAY 14, 2021

In an interview with pharmaphorum’s news editor Richard Staines, chief operating officer Arnout Ploos van Amstel revealed how the biotech and its “mystery CEO” managed to swoop for the drug ahead of big pharma rivals. Licensed in from Ablynx in 2013 five years before a merger with Sanofi, German Merck recognised its potential.

Licensing 58

Licensing Licensing Drugs Marketing 58

The Pharma Data

AUGUST 19, 2020

This acquisition provides an opportunity for the Janssen Pharmaceutical Companies of Johnson & Johnson to broaden its leadership in immune-mediated diseases and drive further growth through expansion into autoantibody-driven disease. Nipocalimab recently received a rare pediatric disease designation from the U.S. An estimated 2.5

Production 40

Production Dermatology Development Containment 40

pharmaphorum

MARCH 19, 2021

This has helped Brew to quickly grow the company and set up working relationships that could progress into new uses for the technology. A host of companies are looking at cough apps to detect the presence of COVID-19. The company’s technology works along a similar principle, using algorithms that have been “trained” to identify coughs.

Marketing 115

Marketing Research Clinical Development Regulation 115

pharmaphorum

APRIL 7, 2021

He spoke to pharmaphorum’s news editor Richard Staines to outline his plans to create a European biotech powerhouse. . With other drugs in the pipeline too, van de Winkel said the company aims to continue to break new ground with next-generation antibody-based therapies. Genmab last year received nearly 4.4

Antibody 64

Antibody Life Science Development Regulation 64

XTalks

APRIL 2, 2024

Additionally, significant mergers and acquisitions featured Spoonshot, a food intelligence firm, being acquired by Target Research Group , and Shore Seaweed, a plant-based protein company, being bought by Scotland’s Aquascot. Highlights include Oatside’s plant-based dairy securing a $73.3

Protein 105

Protein Marketing Development Research 105

pharmaphorum

FEBRUARY 19, 2021

pharmaphorum’s news editor, Richard Staines, discusses the success stories and failures in R&D that have emerged during the Q4 results period. . Many trials were put on hold during the pandemic, but pharma is under pressure to continue with work on new drugs for other diseases. Mixed bag for Biogen. Parkinson’s woes.

Development 40

Development Drugs Trials Medicine 40

Drug Discovery World

FEBRUARY 9, 2024

Catalent and Novo Holdings, a holding and investment company that manages the assets and wealth of the Novo Nordisk Foundation, have entered into a merger agreement under which Novo Holdings will acquire Catalent in an all-cash transaction that values Catalent at $16.5 Novo Holdings will acquire all outstanding shares of Catalent for $63.50

Life Science 102

Life Science Manufacturing Development Production 102

The Pharma Data

MARCH 5, 2021

This acquisition adds Five Prime’s innovative pipeline to Amgen’s leading oncology portfolio. The acquisition of Five Prime also supports Amgen’s international expansion strategy. per share in cash, representing an equity value of approximately $1.9 Bradway, chairman and chief executive officer at Amgen.

Antibody 52

Antibody Trials Development Clinical Development 52

pharmaphorum

APRIL 29, 2021

Founder and CEO Konstantin Mehl spoke to pharmaphorum’s news editor Richard Staines about why these treatments will be in demand as the world emerges from the pandemic. Kaia Health has just announced a $75 million funding round for its technology, aimed at improving musculoskeletal (MSK) and chronic obstructive pulmonary disease (COPD) care.

Production 61

Production Doctors Doctor Clinical Trials 61

Drug Discovery World

JANUARY 15, 2024

The acquisition includes HPN328, an investigational delta-like ligand 3 (DLL3) targeting T-cell engager being evaluated in certain patients with small cell lung cancer and neuroendocrine tumours. The announcement follows the news that Merck agreed a deal with Inspirna for colorectal cancer drug ompenaclid (RGX-202). “At

Clinical Development 105

Clinical Development Clinical Trials Clinical Trials Development 105

Drug Discovery World

APRIL 2, 2024

The post New DDW Highlights podcast: 2 April 2024 appeared first on Drug Discovery World (DDW). DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. You can listen below, or find The Drug Discovery World Podcast on Spotify , Google Play and Apple Podcasts.

FDA Approval 59

FDA Approval Antibody Trials Drugs 59

XTalks

SEPTEMBER 12, 2023

This podcast offers a comprehensive view of noteworthy news stories that are making headlines in the pharma, biotech, healthcare and medical device sectors. The result? A consistent and remarkable growth trajectory, as evidenced by the month-after-month increase in the number of devoted listeners. But how did we achieve this remarkable feat?

Life Science 105

Life Science Branding Clinical Trials Clinical Trials 105

XTalks

JULY 10, 2023

In a twist of fate, Monster Energy may soon become both the savior and executioner of its competitor, Bang Energy. As reported by the Wall Street Journal , Monster Energy is poised to acquire its smaller rival for $362 million through a bankruptcy court agreement. That year, Red Bull led the market with $6.8 billion, according to Statista.

Branding 98

Branding Sales Containment Licensing 98

XTalks

JULY 6, 2023

the family-owned food conglomerate, recently announced its acquisition of Kevin’s Natural Foods , a renowned brand known for its high-quality sous-vide meals, sauces and side dishes. Once the acquisition is finalized, Kevin’s will continue to operate independently as a distinct brand under Mars’ food and nutrition unit.

Branding 96

Branding Sales Packaging Packaging 96

Drug Discovery World

MARCH 7, 2024

By combining chemotherapy with immunotherapy strategies, the company aims to develop new solutions for cancer patients. The post Akari Therapeutics and Peak Bio announce merger appeared first on Drug Discovery World (DDW). The merged pipeline features an antibody-drug conjugate (ADC) toolkit with novel payload and linker technologies.

Antibody 59

Antibody Drugs Clinical Trials Clinical Trials 59

Drug Discovery World

MARCH 29, 2024

News round-up for 25-29 March by DDW Digital Content Editor Diana Spencer. A novel psychedelic compound, combined with psychological support, will be explored as a potential new treatment for people living with alcohol use disorder (AUD) in a Phase IIa study. Could a novel psychedelic treat alcohol use disorder?

Drugs 52

Drugs FDA Approval Antibody Trials 52

XTalks

MAY 15, 2023

The Fairlife milk brand, owned by The Coca-Cola Company, will receive a significant boost of $650 million as the company prepares to construct a new production facility in Webster, upstate New York. The company said the new facility is expected to employ approximately 250 hourly and salaried workers. Fair” Life?

Protein 98

Protein Sales Branding Containment 98

Drug Discovery World

MARCH 25, 2024

Novo Nordisk has acquired Cardior Pharmaeuticals for up to €1.025 billion, including an upfront payment and additional payments if certain milestones are achieved. Cardior is focused on the discovery and development of therapies that target RNA to prevent, repair and reverse diseases of the heart.

Development 52

Development RNA Trials Clinical Development 52

XTalks

MARCH 25, 2021

To complement its leading webinar, editorial and video content, the podcast will explore the latest news and hot topics in the pharmaceutical, biotechnology and medical device spaces. Subscribe to the Xtalks Life Science Podcast to never miss a new episode. Xtalks is proud to announce the launch of the Xtalks Life Science podcast.

Life Science 105

Life Science HR Clinical Trials Clinical Trials 105

XTalks

APRIL 11, 2023

The investment acquisition will see all of Yfood’s venture backers — which include Felix Capital, dairy giant Fonterra, agriculture startup venture capital Five Seasons and several others — sell their shares to Nestlé. Food giant Nestlé has acquired a 49.95 Since the startup’s co-founders will retain a majority of Yfood’s shares (50.05

Allergies 97

Allergies Containment Branding Production 97

XTalks

MARCH 6, 2023

Mayne Pharma Acquisition in Line with Growth Strategy Dr. Reddy’s Laboratories purpose is “Good Health Can’t Wait.” The acquisition of the Mayne Pharma portfolio is important because it provides the North American subsidiary with significant positioning in the field of women’s health.

Production 98

Production Branding Dermatology Hormones 98

Drug Discovery World

MARCH 4, 2024

The acquisition adds long-read DNA and RNA sequencing technologies to Clinical Microbiomics’ multi-omics technologies for the microbiome field. Adding this to our toolbox paves the way for synergies with our bioinformatics and allows for deeper exploration of the microbiome’s complexities that will accelerate new discoveries.”

Bioinformatics 52

Bioinformatics RNA DNA Genome 52

Drug Discovery World

MARCH 1, 2024

Bristol Myers Squibb has completed its acquisition of RayzeBio for approximately $4.1 billion, adding radiopharmaceutical therapeutics (RPTs) to its pipeline. RayzeBio previously reported the interim results of the Phase Ib portion of the ACTION-1 clinical trial, suggesting encouraging efficacy and tolerability.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drugs 52

Drug Discovery World

FEBRUARY 1, 2023

billion raised, new analysis from the UK BioIndustry Association (BIA) and Clarivate shows. New venture capital funds with a mandate to invest in UK biotech were created in 2022, adding another £3.7 However, venture capital investment in the sector was the third-best year recorded for the UK, with £1.2

Life Science 97

Life Science Antibody Marketing Development 97

Drug Discovery World

JANUARY 25, 2024

Japan-based pharma company Kyowa Kirin has successfully completed the acquisition of gene therapy developer Orchard Therapeutics. The post Kyowa Kirin completes acquisition of Orchard Therapeutics appeared first on Drug Discovery World (DDW).

Gene Therapy 52

Gene Therapy Gene Pharma Companies Drugs 52

XTalks

SEPTEMBER 12, 2023

Related: Why Uncrustables Sales Skyrocketed in 2022 Acquisition Details When is the transaction set to conclude? The acquisition, set to finalize in Smucker’s current fiscal year’s third quarter, equates to an adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) multiple of approximately 17.2

Branding 64

Branding Sales Packaging Packaging 64